CA1100407A - Composes renfermant des oestrogenes conjugues synthetiques, et des antioxydants comme agents stabilisateurs - Google Patents

Composes renfermant des oestrogenes conjugues synthetiques, et des antioxydants comme agents stabilisateurs

Info

Publication number
CA1100407A
CA1100407A CA312,018A CA312018A CA1100407A CA 1100407 A CA1100407 A CA 1100407A CA 312018 A CA312018 A CA 312018A CA 1100407 A CA1100407 A CA 1100407A
Authority
CA
Canada
Prior art keywords
sodium
preparation
potassium
alpha
estrogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA312,018A
Other languages
English (en)
Inventor
Johan R.A. Simoons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/836,679 external-priority patent/US4154820A/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1100407A publication Critical patent/CA1100407A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA312,018A 1977-09-26 1978-09-25 Composes renfermant des oestrogenes conjugues synthetiques, et des antioxydants comme agents stabilisateurs Expired CA1100407A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US836,679 1977-09-26
US05/836,679 US4154820A (en) 1976-02-23 1977-09-26 Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers

Publications (1)

Publication Number Publication Date
CA1100407A true CA1100407A (fr) 1981-05-05

Family

ID=25272477

Family Applications (1)

Application Number Title Priority Date Filing Date
CA312,018A Expired CA1100407A (fr) 1977-09-26 1978-09-25 Composes renfermant des oestrogenes conjugues synthetiques, et des antioxydants comme agents stabilisateurs

Country Status (1)

Country Link
CA (1) CA1100407A (fr)

Similar Documents

Publication Publication Date Title
US4154820A (en) Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US5898032A (en) Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
EP2445491B1 (fr) Composition pharmaceutique pour contraception d'urgence
CA1198057A (fr) Methode de contraception par administration de progestogene
DE60130147T2 (de) Verwendung oraler formulierungen zur behandlung der weiblichen sexuellen störung
US3568828A (en) Modified sequential oral contraceptive
US5552394A (en) Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
DE102005034498A1 (de) Orale Kontrazeption mit Trimegeston
CN113750108A (zh) 用于过重女性患者的基于屈螺酮的避孕药
DE4229820A1 (de) Pharmazeutische Zubereitung auf Gestagen-Basis
US20030018018A1 (en) Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea
JPS5938203B2 (ja) 補酵素qを主成分とする脳循環障害治療剤
CA1256802A (fr) Association synergique contraceptive
CA1100407A (fr) Composes renfermant des oestrogenes conjugues synthetiques, et des antioxydants comme agents stabilisateurs
JP2942560B2 (ja) エストロゲン欠乏症治療用組成物
US5834451A (en) Remedy for myotonic dystrophy
DE60035771T2 (de) Verwendung eines den Plasmahomocysteingehalt reduzierenden Wirkstoffs zur Verminderung des Risikos von durch Hormone vom Gestagentyp hervorgerufenen thromboembolischen Nebenwirkungen
US3660574A (en) Method of controlling fertility employing quingestanol acetate
US4105794A (en) Process of mitigating cholelithiasis
US3322628A (en) Method of treatment of headaches
Soudah Bio-Identical hormone treatment as a functional approach to treat Asherman's Syndrome
US5017384A (en) Medicinal composition for regularizing hormonal secretion and for treating sterility
Widholm et al. The use of conjugated oestrogen in oral contraception
Nuttall et al. The effect of norethisterone capsules on the pituitary-ovarian axis
DE102005023301A1 (de) Pharmazeutische Zusammensetzung enthaltend Gestagene und/oder Estrogene und 5-Methyl-(6S)-tetrahydrofolat

Legal Events

Date Code Title Description
MKEX Expiry